FDA Inspection 1292892 — MannKind Corporation
The FDA completed an inspection of MannKind Corporation on November 4, 2025 in Danbury, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 4, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Danbury, CT (United States)